CXCL12 and glioblastoma: Overexpression of CXCR4 in anti-EGFRvIII CAR NK cells results in increased chemotaxis toward CXCL12/SDF-1α-secreting glioblastoma cells, complete tumor remission in a number of mice, and increased overall survival [153].